Literature DB >> 19650664

Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.

Sumin Cai1, Feng He, Hardeep S Samra, Luis M de la Maza, Maria E Bottazzi, Sangeeta B Joshi, C Russell Middaugh.   

Abstract

Native Chlamydia trachomatis mouse pneumonitis major outer membrane protein (nMOMP) induces effective protection against genital infection in a mouse challenge model. The conformation of nMOMP is crucial to confer this protective immunity. To achieve a better understanding of the conformational behavior and stability of nMOMP, a number of spectroscopic techniques are employed to characterize the secondary structure (circular dichroism), tertiary structure (intrinsic fluorescence) and aggregation properties (static light scattering and optical density) as a function of pH (3-8) and temperature (10-87.5 degrees C). The data are summarized in an empirical phase diagram (EPD) which demonstrates that the thermal stability of nMOMP is strongly pH-dependent. Three distinctive regions are seen in the EPD. Below the major thermal transition regions, nMOMP remains in its native conformation over the pH range of 3-8. Above the thermal transitions, nMOMP appears in two different structurally altered states; one at pH 3-5 and the other at pH 6-8. The EPD shows that the highest thermal transition point ( approximately 65 degrees C) of nMOMP is near pH 6. Several potential excipients such as arginine, sodium citrate, Brij 35, sucrose and guanidine are also selected to evaluate their effects on the stability of nMOMP. These particular compounds increase the aggregation onset temperature of nMOMP by more than 10(omicron)C, without affecting its secondary and tertiary structure. These results should help formulate a vaccine using a recombinant MOMP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19650664      PMCID: PMC2757499          DOI: 10.1021/mp900110q

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  32 in total

Review 1.  The potential for vaccine development against chlamydial infection and disease.

Authors:  R C Brunham; D J Zhang; X Yang; G M McClarty
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

2.  Role of hydration of polyhydroxy compounds in biological systems.

Authors:  H Uedaira; H Uedaira
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2001-07       Impact factor: 1.770

Review 3.  Chlamydial genomics and vaccine antigen discovery.

Authors:  R S Stephens
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

4.  Sexual health--health of the nation.

Authors:  M W Adler
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

5.  Preferential hydration and the exclusion of cosolvents from protein surfaces.

Authors:  Seishi Shimizu; Derek J Smith
Journal:  J Chem Phys       Date:  2004-07-08       Impact factor: 3.488

6.  Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study.

Authors:  Lisa A Kueltzo; Baran Ersoy; John P Ralston; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2003-09       Impact factor: 3.534

7.  The stabilization of proteins by sucrose.

Authors:  J C Lee; S N Timasheff
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

8.  Prevalence of chlamydial and gonococcal infections among young adults in the United States.

Authors:  William C Miller; Carol A Ford; Martina Morris; Mark S Handcock; John L Schmitz; Marcia M Hobbs; Myron S Cohen; Kathleen Mullan Harris; J Richard Udry
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

9.  Chlamydia trachomatis infection in asymptomatic men.

Authors:  D Scott LaMontagne; David N Fine; Jeanne M Marrazzo
Journal:  Am J Prev Med       Date:  2003-01       Impact factor: 5.043

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  7 in total

Review 1.  A rational, systematic approach for the development of vaccine formulations.

Authors:  Garry L Morefield
Journal:  AAPS J       Date:  2011-02-23       Impact factor: 4.009

2.  Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine.

Authors:  Delia F Tifrea; Guifeng Sun; Sukumar Pal; Gustavo Zardeneta; Melanie J Cocco; Jean-Luc Popot; Luis M de la Maza
Journal:  Vaccine       Date:  2011-05-06       Impact factor: 3.641

Review 3.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

4.  Long-term stability of a vaccine formulated with the amphipol-trapped major outer membrane protein from Chlamydia trachomatis.

Authors:  H Eric Feinstein; Delia Tifrea; Guifeng Sun; Jean-Luc Popot; Luis M de la Maza; Melanie J Cocco
Journal:  J Membr Biol       Date:  2014-06-19       Impact factor: 1.843

5.  Urine metabolome in women with Chlamydia trachomatis infection.

Authors:  Claudio Foschi; Luca Laghi; Antonietta D'Antuono; Valeria Gaspari; Chenglin Zhu; Nicolò Dellarosa; Melissa Salvo; Antonella Marangoni
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

6.  Effect of Sugars on Chlamydia trachomatis Infectivity.

Authors:  Giacomo Marziali; Antonella Marangoni; Claudio Foschi; Maria Carla Re; Natalia Calonghi
Journal:  Pathogens       Date:  2020-04-17

7.  Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation.

Authors:  Robert W Hepler; Debbie D Nahas; Bob Lucas; Robin Kaufhold; Jessica A Flynn; Jennifer D Galli; Ryan Swoyer; James M Wagner; Amy S Espeseth; Joseph G Joyce; James C Cook; Eberhard Durr
Journal:  Protein Sci       Date:  2018-11       Impact factor: 6.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.